- Home
- SERA vs VANI Comparison
SERA vs VANI Comparison
Compare SERA & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- VANI
- Stock Information
- Founded
- SERA 2008
- VANI 1998
- Country
- SERA United States
- VANI United States
- Employees
- SERA N/A
- VANI N/A
- Industry
- SERA Precision Instruments
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SERA Health Care
- VANI Health Care
- Exchange
- SERA Nasdaq
- VANI Nasdaq
- Market Cap
- SERA 90.6M
- VANI 75.8M
- IPO Year
- SERA 2021
- VANI 2014
- Fundamental
- Price
- SERA $3.25
- VANI $1.40
- Analyst Decision
- SERA
- VANI Strong Buy
- Analyst Count
- SERA 0
- VANI 1
- Target Price
- SERA N/A
- VANI $4.00
- AVG Volume (30 Days)
- SERA 64.5K
- VANI 206.6K
- Earning Date
- SERA 11-05-2025
- VANI 11-12-2025
- Dividend Yield
- SERA N/A
- VANI N/A
- EPS Growth
- SERA N/A
- VANI N/A
- EPS
- SERA N/A
- VANI N/A
- Revenue
- SERA $108,000.00
- VANI N/A
- Revenue This Year
- SERA $217.92
- VANI N/A
- Revenue Next Year
- SERA $479.25
- VANI N/A
- P/E Ratio
- SERA N/A
- VANI N/A
- Revenue Growth
- SERA 0.94
- VANI N/A
- 52 Week Low
- SERA $1.37
- VANI $0.91
- 52 Week High
- SERA $9.13
- VANI $1.80
- Technical
- Relative Strength Index (RSI)
- SERA 58.22
- VANI 51.62
- Support Level
- SERA $2.87
- VANI $1.39
- Resistance Level
- SERA $3.12
- VANI $1.54
- Average True Range (ATR)
- SERA 0.23
- VANI 0.11
- MACD
- SERA -0.02
- VANI 0.00
- Stochastic Oscillator
- SERA 63.77
- VANI 53.85
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.